How PTSD Is Treated Today: What Works, and What Order to Try It In

Summary

PTSD has a short list of treatments that genuinely work, and a real order to the work. Three talk therapies carry the strongest recommendation in the US guideline — Cognitive Processing Therapy, EMDR, and Prolonged Exposure — and three more are named as good options, one of which runs just five sessions with no homework. Exactly two medicines are FDA-approved for PTSD in adults: sertraline and paroxetine. A third, venlafaxine, is strongly recommended without being approved. Sleep and nightmares usually need their own line on the plan. The single best predictor of whether a treatment helps is whether you can actually do it — so the option you can start next week may beat the one with a five-month wait.

Zoom

Why This Matters Now

A tailor does not start with scissors. She starts with a tape measure, then a pattern, then a basted seam you try on before anything is cut. If the shoulders are wrong, nothing she does to the sleeve will save the jacket. And the finest coat in the shop does you no good hanging in the closet.

Treating PTSD works the same way. There is a short list of good patterns, a real order to the work, and one measure that matters more than any other — whether you will actually wear it.

The Short List

Six treatments carry most of the evidence.

Three carry the strongest recommendation in the US guideline: Cognitive Processing Therapy, EMDR, and Prolonged Exposure. Three more are suggested as options: Cognitive Therapy for PTSD, Present-Centered Therapy, and Written Exposure Therapy. [1] In guideline language, “recommend” is the strong word and “suggest” is the softer one.

Most are trauma-focused. The work touches the memory itself, and the beliefs the event left behind. Present-Centered Therapy leaves memory work out on purpose, and it still beats waiting for treatment. [2]

All six are manualized, meaning the therapist follows a protocol that was tested in studies.

The guideline suggests starting with therapy when you can. It does not say medicine is second-rate — three medicines carry a strong recommendation too. [1] In studies, the therapies move symptoms more than the medicines do. But the studies were not built to compare them head to head, so treat that as a rough impression rather than a verdict. [20]

Two people with the same diagnosis can get different first plans, and both are correct. One starts Cognitive Processing Therapy because her clinic has a trained therapist. The other starts a medicine because the nearest trauma therapist has a five-month wait. Neither is settling. The pattern gets fitted to the person.

Two of the strongest options have also been compared directly. In US veterans, Prolonged Exposure and Cognitive Processing Therapy performed similarly. [4] That is genuinely useful news: it means the choice between them can be made on fit and availability rather than on a ranking.

What These Therapies Ask of You — and What They Don’t

Less than most people expect.

You do not have to tell every detail, and you do not have to narrate the event out loud. You do not have to be “stable enough” first. No guideline requires a stabilization phase. Safety planning runs alongside treatment, not as a gate in front of it. Suicidal thoughts are not a reason to be turned away.

A trial that removed the written trauma account from Cognitive Processing Therapy found no difference in results — and better retention without it. [9]

The stories below are fictional composites. No real people or identifying details are involved.

A warehouse supervisor has turned down therapy twice. Both times the pitch was the same: twelve weeks, ninety-minute sessions, tapes to play at home. He works rotating shifts, and he fears that if he starts talking he will not stop. Then someone offers five sessions, with the writing done in the room. He finishes it.

That option is Written Exposure Therapy. You write about the event for thirty minutes in the room. It is scripted, timed, and therapist-led — not something to do alone. Across three trials it matched the longer treatments, and far more people finished: dropout of 6.4%, 24%, and 12.5%, against 39.7%, 45%, and 35.6%. [8][9] Dropout is not a footnote in PTSD care. Which protocol is offered measurably changes how many people finish it. [19]

Worry about getting worse is understandable, and the data run the other way. Deterioration happened in under 1% of people in talk therapies, and about 11% of those given no treatment. Still, only 36% of trials reported side effects at all, so this is not risk-free. [3]

Here is the honest ceiling. These treatments help a lot of people a lot, and they do not reliably erase the diagnosis. In one 2023 trial, about 60% of people in both arms still met PTSD criteria at 30 weeks. [8] That is not a reason to skip treatment. It is a reason to define what “better” means for you at the start, rather than measuring success only as the diagnosis disappearing.

One more thing worth clearing up: EMDR is not hypnosis. There is no trance and no suggestion. You stay awake and oriented, and you can stop a set at any point. The side task competes for your attention rather than narrowing it, which runs opposite to hypnosis. EMDR is an eight-phase manual, and the guideline backs the whole package. [1]

Medicines: Approved, Recommended, and Off-Label

Exactly two medicines are FDA-approved for PTSD in adults: sertraline and paroxetine immediate-release. No medicine is FDA-approved for PTSD in anyone under 18.

A third, venlafaxine extended-release, carries a strong guideline recommendation — and PTSD appears nowhere on its label. [1] That is normal, and worth knowing before you read the pharmacy printout and wonder whether someone made a mistake.

“Approved” means the FDA reviewed evidence for that exact use and put it on the label. “Off-label” means it is used for something else. Off-label is legal, common, and sometimes strongly recommended.

A third group causes the most confusion. Someone with PTSD may also take a medicine aimed at sleep, pain, or mood. That one is not treating PTSD.

A woman leaves an appointment with four new prescriptions and one sentence in her head: “these are for your PTSD.” Six weeks later nothing is better, and she decides she is a hard case. One was for sleep, one for nerve pain, one for depression, and one was aimed at PTSD. Nothing had its own target or check-in, so nothing could be judged, adjusted, or stopped.

If a medicine is working, stopping it early raises the odds symptoms return. After 36 weeks of steady treatment, relapse over the next 28 weeks was 5% on sertraline and 26% on placebo. [17] Plan the ending with your prescriber, and do not start, stop, or change any prescription on your own.

The antidepressants are also not interchangeable. Three are strongly recommended, one sits at “neither for nor against,” and several fall under “not enough evidence.” [1] One equivalence finding is real but narrow: a pooled analysis found no difference among three specific medicines. That is not the same as “they all work about the same.”

Sleep and Nightmares Get Their Own Plan

Sleep often needs its own line on the plan. You can be doing well in trauma therapy and still wake at 3 a.m. every night. Expect that, rather than reading it as treatment failure.

CBT-I is a short, structured treatment for insomnia. It is not a list of sleep hygiene tips. It changes when and how long you are in bed, and what you do when you cannot sleep. In people with PTSD it produced the largest insomnia effect of any group studied. It helped PTSD symptoms in the short term, but that faded at follow-up while the sleep benefit held. Treating insomnia is worth doing on its own merits, and it does not replace trauma-focused treatment.

Prazosin is the medicine people ask about most here, and it is a genuinely instructive case. The same guideline suggests it for PTSD nightmares and against it for PTSD in general. [1] Two opposite calls, one medicine. The numbers match that split: a moderate effect on nightmares and sleep, and a small, inconsistent effect on overall PTSD that was not significant in the largest and most recent pooled analysis. [15][16] The biggest trial, in 304 veterans, missed all three of its main outcomes. [14] Later analyses still find a real effect on nightmares. [16] The difference is the target, not the quality of the medicine. Do not start or stop it on your own.

If you snore, stop breathing in your sleep, or stay worn out no matter what, ask about a sleep study. Sleep apnea is far more common in PTSD than people guess. [12] Untreated, it can make everything else look like treatment failure. And it is diagnosed with a sleep test, not a questionnaire — in younger veterans with PTSD and insomnia, the usual screening questionnaire did not reliably detect who had it. [13]

Order, Combining, and What “It Isn’t Working” Really Means

Pick a proven option you can actually do. Run it long enough to judge. Measure whether it worked. Then change one thing.

Combining therapy and medicine is a reasonable choice, not a guideline step. The guideline finds the evidence insufficient either way. [1] In the largest three-arm trial, with 228 people, remission was 65.5% for Prolonged Exposure alone, 43.3% for paroxetine alone, and 51.2% for both. [18] Combining did not beat either one on its own.

Changing one thing at a time is slower and works better. If a dose changes, a therapy starts, and a sleep medicine is added in one week, nobody can say what helped. Alterations go in one at a time for that reason. Ask for one change, one target, and one date to check it.

There is no official definition of “treatment-resistant PTSD.” If someone uses the phrase, ask what they mean by it. A few plain questions come first. Was the diagnosis right? Did the treatment get a fair run? Is there ongoing danger at home? Is pain, a head injury, or untreated sleep apnea in the way?

That last question matters more than it sounds. A veteran stuck for months, with “treatment-resistant” starting to show up in conversation, turned out to stop breathing in his sleep. His wife had been saying so for years. Treating it changed how he felt every day.

A first treatment that did not work says nothing about you. Switching among the strongly recommended medicines carries no expected advantage either way. Adding trauma-focused therapy to a medicine that stalled helped partial responders. And the guideline names three more therapies for when a first one is declined or does not work. [1]

Where to Be Careful

The US guideline recommends against only two treatments at full strength: benzodiazepines and cannabis. [1]

For benzodiazepines, the case is built on harm rather than on failed efficacy trials. A review of 18 studies and 5,236 people found worse PTSD severity, a higher risk of developing PTSD when the medicines were used soon after trauma, and worse therapy outcomes. [10] Trauma-focused therapy depends on new learning, and these medicines blunt exactly that.

For cannabis, the only randomized placebo-controlled trial did not beat placebo. [11] Many people find it helps them sleep, and that experience is real. It is just not what the trial showed.

If you already take either one, talk with your prescriber. Do not stop on your own — stopping a benzodiazepine abruptly can be dangerous.

Myths vs Facts

Risks, Limitations, and Uncertainties

The strong parts are genuinely strong. Trauma-focused therapies beat control conditions across many trials, two FDA-approved medicines exist, and telehealth delivery carries the guideline’s strongest rating. [1][5] None of that is a close call.

Several things are much less settled. Whether therapy truly outperforms medicine is not established, because the trials were not designed to answer it. [20] Whether combining them helps is formally rated insufficient. [1] There is no accepted definition of treatment-resistant PTSD, so the phrase means whatever the speaker intends. And the durability question is real: benefits are measured over months, not years, in most trials.

The evidence is also thinner than it looks for many of the people who most need it. Most PTSD trials excluded people with self-harm, recent suicidal thoughts, psychosis, bipolar I, or active substance use. These treatments are still used in those situations, and often should be — but the confidence behind them is lower than the headline numbers suggest.

Safety reporting is a weak spot worth naming. Only about a third of psychotherapy trials reported adverse events at all, which means “well tolerated” rests on incomplete data. [3]

Two practical cautions. Therapy names are not legally protected in most places, so a clinic can advertise a protocol without anyone on staff having completed the training. And no supplement or over-the-counter product has been shown to treat PTSD.

What This Means for You

Here is a simple guide that sorts what you might notice into three levels.

Track it and mention it at the next visit: sleep that is still rough while the rest improves, a plateau after early gains, side effects that are mild and easing, questions about how long to stay on a medicine.

Call the prescriber or therapist soon: no change at all after a fair run at a full dose, symptoms clearly getting worse, new or worsening nightmares, a bad reaction to a medicine, snoring or witnessed pauses in breathing, or dark thoughts without a plan.

Get help now — call or text 988, or call 911: a plan or intent to harm yourself or someone else, or any medical emergency.

Two more things help at the start.

First, ask for the treatment by name: “Cognitive Processing Therapy,” “Prolonged Exposure,” “EMDR,” “Written Exposure Therapy.” Then ask whether the person you are sent to was formally trained in it. A weekend workshop is not full training.

Second, ask for a number at the start and along the way. A short questionnaire, filled out every few weeks, turns “I think it’s helping” into something you can both see.

Questions to Ask Your Prescriber or Therapist

• Which of the recommended treatments do you offer, and were you formally trained in it?
• How soon can I actually start, and what is the wait for the alternatives?
• What measure will we use, and how often will we check it?
• How long before we should expect to see a change?
• If this does not work, what is the next step?
• Which of my medicines is aimed at PTSD, and which are for something else?
• Does my sleep need its own plan?
• How and when would we stop any of this later?

Frequently Asked Questions

Q: Which treatment should I ask for first?

Ask about the three strongest: Cognitive Processing Therapy, EMDR, and Prolonged Exposure. Then ask which you can start soon. An option available next week may beat one with a five-month wait.

Q: Do I have to describe what happened in detail?

No. One recommended treatment leaves detailed retelling out entirely. Another does the writing in the room and sends nothing home. [2][8]

Q: Everything on my list says it is for PTSD. Is that true?

Often not. Only sertraline and paroxetine immediate-release are FDA-approved for PTSD in adults. Some medicines are strongly recommended without being approved. Others are aimed at sleep, pain, or mood. Ask what each one is for.

Q: Does treatment work over video?

Yes. The guideline recommends it at full strength. In one trial, clinician-rated scores showed no real difference between in-home, video, and in-office care. [1][5] Online therapist-assisted programs have also been tested directly. [6]

Q: Were people like me in these studies?

Maybe not. Most PTSD trials excluded people with self-harm, recent suicidal thoughts, psychosis, bipolar I, or active substance use. These treatments are still used there, but the evidence is thinner.

Q: What about children and teenagers?

No medicine is FDA-approved for PTSD in anyone under 18. Therapy for children exists and is worth seeking. Ask for a clinician who treats young people.

Q: Can I do a shorter, more intensive version?

Sometimes. Massed delivery — the same treatment compressed into about two weeks — did as well as the weekly schedule in a randomized trial. [7] Ask whether anyone near you offers it.

Q: How long until I know if it is working?

Ask for a specific date at the start, and a specific measure. That turns a vague wait into a decision point.

Key Takeaways

• Six treatments carry most of the evidence. Three are strongest — Cognitive Processing Therapy, EMDR, and Prolonged Exposure — and Written Exposure Therapy runs five sessions with no homework. [1]
• Exactly two medicines are FDA-approved for PTSD in adults; venlafaxine is strongly recommended without being approved. [1]
• You do not have to be stable first, and you do not have to tell every detail. [1][9]
• Sleep, nightmares, and possible sleep apnea usually need their own line on the plan. [12][13][16]
• Change one thing at a time, with one target and one date to check it — and never start or stop a prescription on your own.

If You Only Remember One Thing…

The best PTSD treatment is a proven one you can actually start and actually finish.

Conclusion

Good PTSD care is fitting work. There is a pattern that fits most people, a seam you try on before anything is cut, and alterations made one at a time so you can tell which one helped. Forget the jacket that looks best on the rack. The goal is the one you will put on tomorrow morning. Recovery is possible, and the next essay in this series covers the newer treatments you have probably been reading about.

This article is for education only — it is not medical advice. It cannot account for your history, your other conditions, or your medicines. Talk with your prescriber before you:

• Start or stop any medication
• Change a dose or skip a dose
• Add a supplement or over-the-counter remedy
• Make a major health decision

Related reading

• The Many Faces of PTSD: Why It Almost Never Looks Like the Movies
• The Future of PTSD Treatment: Sorting the Promising From the Premature
• Understanding PTSD and Dissociative Symptoms

References

1. US Department of Veterans Affairs, US Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder. Version 4.0. June 2023. Recommendations 7, 8, 9, 15, 18, 19, 20, 21, 22, 29, 32. https://www.healthquality.va.gov/guidelines/MH/ptsd/. Accessed August 5, 2026.

2. Belsher BE, Beech E, Evatt D, et al. Present-centered therapy (PCT) for post-traumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev. 2019;11:CD012898. doi:10.1002/14651858.CD012898.pub2. PMID:31742672.

3. Hoppen TH, Lindemann AS, Morina N. Safety of psychological interventions for adult post-traumatic stress disorder: meta-analysis on the incidence and relative risk of deterioration, adverse events and serious adverse events. Br J Psychiatry. 2022;221(5):658-667. doi:10.1192/bjp.2022.111. PMID:35959698.

4. Schnurr PP, Chard KM, Ruzek JI, et al. Comparison of prolonged exposure vs cognitive processing therapy for treatment of posttraumatic stress disorder among US veterans: a randomized clinical trial. JAMA Netw Open. 2022;5(1):e2136921. doi:10.1001/jamanetworkopen.2021.36921. PMID:35044471.

5. Peterson AL, Mintz J, Moring JC, et al. In-office, in-home, and telehealth cognitive processing therapy for posttraumatic stress disorder in veterans: a randomized clinical trial. BMC Psychiatry. 2022;22(1):41. doi:10.1186/s12888-022-03699-4. PMID:35038985.

6. Ehlers A, Wild J, Warnock-Parkes E, et al. Therapist-assisted online psychological therapies differing in trauma focus for post-traumatic stress disorder (STOP-PTSD): a UK-based, single-blind, randomised controlled trial. Lancet Psychiatry. 2023;10(8):608-622. doi:10.1016/S2215-0366(23)00181-5. PMID:37479341.

7. Dell L, Sbisa AM, Forbes A, et al. Effect of massed v. standard prolonged exposure therapy on PTSD in military personnel and veterans: a non-inferiority randomised controlled trial. Psychol Med. 2023;53(9):4192-4199. doi:10.1017/S0033291722000927. PMID:35440345.

8. Sloan DM, Marx BP, Acierno R, et al. Written exposure therapy vs prolonged exposure therapy in the treatment of posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2023;80(11):1093-1100. doi:10.1001/jamapsychiatry.2023.2810. PMID:37610727.

9. Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018;75(3):233-239. doi:10.1001/jamapsychiatry.2017.4249. PMID:29344631.

10. Guina J, Rossetter SR, DeRhodes BJ, et al. Benzodiazepines for PTSD: a systematic review and meta-analysis. J Psychiatr Pract. 2015;21(4):281-303. doi:10.1097/PRA.0000000000000091. PMID:26164054.

11. Bonn-Miller MO, Sisley S, Riggs P, et al. The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: a randomized cross-over clinical trial. PLoS One. 2021;16(3):e0246990. doi:10.1371/journal.pone.0246990. PMID:33730032.

12. Zhang Y, Weed JG, Ren R, et al. Prevalence of obstructive sleep apnea in patients with posttraumatic stress disorder and its impact on adherence to continuous positive airway pressure therapy: a meta-analysis. Sleep Med. 2017;36:125-132. doi:10.1016/j.sleep.2017.04.020. PMID:28735910.

13. Lyons R, Barbir LA, Owens R, et al. STOP-BANG screener vs objective obstructive sleep apnea testing among younger veterans with PTSD and insomnia. J Clin Sleep Med. 2022;18(1):67-73. doi:10.5664/jcsm.9498. PMID:34216197.

14. Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018;378(6):507-517. doi:10.1056/NEJMoa1507598. PMID:29414272.

15. Reist C, Streja E, Tang CC, et al. Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis. CNS Spectr. 2021;26(4):338-344. doi:10.1017/S1092852920001121. PMID:32362287.

16. Mendes TP, Pereira BG, Coutinho ESF, et al. Factors impacting prazosin efficacy for nightmares and insomnia in PTSD patients: a systematic review and meta-regression analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2025;136:111253. doi:10.1016/j.pnpbp.2025.111253. PMID:39828080.

17. Davidson J, Pearlstein T, Londborg P, et al. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry. 2001;158(12):1974-1981. doi:10.1176/appi.ajp.158.12.1974. PMID:11729012.

18. Popiel A, Zawadzki B, Pragłowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident: a randomized clinical trial (the TRAKT study). J Behav Ther Exp Psychiatry. 2015;48:17-26. doi:10.1016/j.jbtep.2015.01.002. PMID:25677254.

19. Penix-Smith EA, Swift JK. The protocol matters: a meta-analysis of psychotherapy dropout from specific PTSD treatment approaches in U.S. service members and veterans. Psychol Trauma. 2025. doi:10.1037/tra0002070. PMID:41248050.

20. Forman-Hoffman V, Middleton JC, Feltner C, et al. Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update. Comparative Effectiveness Review No. 207. Rockville, MD: Agency for Healthcare Research and Quality; 2018. NCBI Bookshelf NBK525134. PMID:30204376.

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, available 24/7. En español: marque 988 y oprima 2. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.